Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating expenses:
Research and development expenses	$ 17,760	$ 13,541
General and administrative expenses	8,159	5,238
Total operating expenses	25,919	18,779
Loss from operations	(25,919)	(18,779)
Other income (expense):
Interest income	3,206	2,320
Interest expense	(2)	(3)
Other income	148	143
Other expense	(80)	(602)
Net loss	$ (22,647)	$ (16,921)
Per share information:
Net loss per share, basic (in dollars per share)	$ (1.08)	$ (1.00)
Net loss per share, diluted (in dollars per share)	$ (1.08)	$ (1.00)
Weighted-average shares of common stock outstanding, basic (in shares)	20,996,287	16,903,735
Weighted-average shares of common stock outstanding, diluted (in shares)	20,996,287	16,903,735